Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing

The invention relates to methods involving MS4A12 and agents targeting MS4A12 which are useful for therapy, diagnosis and testing of disease states, in particular cancer diseases. In particular, the invention relates to agents which reduce or inhibit expression or activity of MS4A12, compositions containing these agents, and methods for reducing, determining, or increasing the responsiveness of a cell towards EGF.

Patents:
EP 2,265,718   [MORE INFO]

Inventor(s): SAHIN UGUR [DE]; TUERECI OEZLEM [DE]; KOSLOWSKI MICHAEL [DE]

Type of Offer: Sale



« More Medical Patents

---